Form D · Other Health Care
Aspire Therapy Holdings LP
Dallas, TX · CIK 0002082689
Offering snapshot reported Jul 14, 2026 · SEC filing
- Reported sold
- $7.01M Indefinite offering
- Investors reported
- 38 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 16, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 14, 2026 | Initial | $7,008,333 | No comparison | 38 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-590670
Source: Form D, filed Jul 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Aspire Therapy Holdings Gp Llc | Director |
| Sonia Ponnusamy | Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
100 Crescent Court Suite 700
Dallas, TX, 75201
Dallas, TX, 75201